Skip to main content
PMC home page
PLOS ONE logoLink to PLOS ONE
. 2019 Sep 9;14(9):e0222473. doi: 10.1371/journal.pone.0222473

Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease

Fatma N Hamed, Annika Åstrand, Marta Bertolini, Alfredo Rossi, Afsaneh Maleki-Dizaji, Andrew G Messenger, Andrew J G McDonagh, Rachid Tazi-Ahnini
PMCID: PMC6733453  PMID: 31498852

The following information is missing from the Funding section: MB received funding from the National Alopecia Areata Foundation (USA) and Associazione Mediterranea Alopecia Areata (Italy).

Reference

  • 1.Hamed FN, Åstrand A, Bertolini M, Rossi A, Maleki-Dizaji A, Messenger AG, et al. (2019) Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease. PLoS ONE 14(7): e0210308 10.1371/journal.pone.0210308 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES